LELAIS, GERALD,JIANG, SONGCHUN,EPPLE, ROBERT,MARSILJE, III, THOMAS H.,MICHELLYS, PIERRE-YVES,MCNEILL, MATTHEW H.,LONG, YUN,LU, WENSHUO,CHEN, BEI,BURSULAYA, BADRY
申请号：
MYPI 2014003216
公开号：
MY165036A
申请日:
2013.06.05
申请国别(地区):
MY
年份:
2018
代理人:
摘要：
THE INVENTION PROVIDES COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, WHICH ARE USEFUL FOR MODULATING EGFR ACTIVITY, AS WELL AS METHODS FOR USING SUCH COMPOUNDS TO TREAT, AMELIORATE OR PREVENT A CONDITION ASSOCIATED WITH ABNORMAL OR DEREGULATED EGFR ACTIVITY.
